Edwards prevails in USPTO review with Boston Scientific transcatheter valve patent
Edwards Lifesciences announced the USPTO decided in Edwards' favor in an Inter Partes Review of Boston Scientific's U.S. transcatheter heart valve patent, number 8,992,608. The USPTO determined that all claims of the '608 patent that have been asserted against Edwards are invalid. March 24, 2018